Navigation Links
HemaQuest Pharmaceuticals Completes Patient Enrollment in Phase 2 Clinical Study of HQK-1001 in Patients With Sickle Cell Disease
Date:9/12/2011

ard-looking statements" within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. You should be aware that our actual results could differ materially from those contained in the forward-looking statements, which are based on management's current expectations and are subject to a number of risks and uncertainties, including, but not limited to, our failure to successfully commercialize our product candidates; costs and delays in the development and/or FDA approval, or the failure to obtain such approval, of our product candidates; uncertainties or differences in interpretation in clinical trial results; our inability to maintain or enter into, and the risks resulting from our dependence upon, collaboration or contractual arrangements necessary for the development, manufacture, commercialization, marketing, sales and distribution of any products; competitive factors; our inability to protect our patents or proprietary rights and obtain necessary rights to third party patents and intellectual property to operate our business; our inability to operate our business without infringing the patents and proprietary rights of others; general economic conditions; the failure of any products to gain market acceptance; our inability to obtain any additional required financing; technological changes; government regulation; changes in industry practice; and one-time events. We do not intend to update any of these factors or to publicly announce the results of any revisions to these forward-looking statements.CONTACTS:

Jerome Lyons

Tamara A. SeymourOffice Manager

Chief Financial OfficerT: 206.826.9900

T: 858.356.5582jlyons@hemaquest.com

tseymour@hemaquest.com
'/>"/>

SOURCE HemaQuest Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. HemaQuest Pharmaceuticals Announces First Patient Enrolled in Phase 2 Clinical Study of HQK-1001 in Patients With Sickle Cell Disease
2. HemaQuest Pharmaceuticals, Inc. Presents Promising Clinical Results at 52nd Annual Meeting of the American Society of Hematology (ASH)
3. HemaQuest Announces Appointment of New Executive Management Team; Company Establishes Headquarters in San Diego
4. HemaQuest Pharmaceuticals Raises Additional $4M to Bring Total to $16M in Series B Financing
5. Optimer Pharmaceuticals DIFICID Featured in 11 Presentations at 51st ICAAC
6. AcelRx Pharmaceuticals to Present at the Rodman & Renshaw Global Investment Conference
7. Valeant Pharmaceuticals Announces Mailing of Offer and Take-Over Bid Circular to Shareholders of Afexa
8. Rescheduled Webcast: Isis Pharmaceuticals Hosts Dr. John Kastelein to Review Mipomersen Long-term Data Recently Presented at ESC Congress 2011
9. Anthera Pharmaceuticals Announces Notice of Allowance of U.S. Patent Application Covering A-002 Plus Statin Compositions
10. Panmira and FLAP LLCs Spun Out of Amira Pharmaceuticals
11. Oramed Pharmaceuticals to Present at Rodman & Renshaw 13th Annual Global Investment Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/17/2014)... , Sept. 17, 2014 Mindray (NYSE: ... officially released worldwide. The system has been showcased for ... during 14-17th September, and is scheduled for ... Designed to be the most efficient workhorse in ... diagnostic tools with a perfectly optimized user experience including ...
(Date:9/17/2014)... , September 17, 2014 ... to congratulate Biocartis commitment in shipping its first ... long-time investor in Biocartis as part of Debiopharm ... fully automated, real-time PCR based molecular diagnostics system, ... access to clinical molecular diagnostic information, anywhere and ...
(Date:9/16/2014)... Hologic, Inc. (NASDAQ: HOLX ... del Tomcat, un nuovo strumento preanalitico marcato CE ... automatizzata, progettata per semplificare la fase preanalitica ed ... errore legati alla gestione manuale dei campioni. ... riduce il carico di lavoro legato al trasferimento ...
Breaking Medicine Technology:Quality Exams at Your Fingertips 2Debiopharm Diagnostics Portfolio Company Biocartis Ships its First Idylla Instrument 2Hologic annuncia il lancio dello strumento preanalitico Tomcat in Europa 2Hologic annuncia il lancio dello strumento preanalitico Tomcat in Europa 3
... Par Pharmaceutical Companies, Inc. (NYSE: PRX ) will ... Friday, January 6, 2012 at the Millennium Hotel, 145 West ... Patrick G. LePore, and other members of the senior management ... current products and pipelines, and business outlook to analysts and ...
... Concord Medical Services Holdings Limited (the "Company" or "Concord ... largest network of radiotherapy and diagnostic imaging centers in ... Twelfth Annual CCM Academic Conference in Beijing on December ... conference, doctors and researchers shared their clinical and academic ...
Cached Medicine Technology:Concord Medical Completes its Twelfth Annual Academic Conference 2Concord Medical Completes its Twelfth Annual Academic Conference 3
(Date:9/17/2014)... 2014 As kids settle back ... top of mind for parents, teachers and coaches. ... about concussions and an informative video, Pediatric Concussions: ... coaches and teachers to detect, talk about and ... a pediatric orthopedic surgeon, I witness youth sports ...
(Date:9/17/2014)... 17, 2014 ICS Learning Group, Inc. ... Excellence in Training for the Best Use of Games ... on an online operational safety training module that ICS ... operation. Using an approach that combined realistic 3D ... that was similar to a video game, including competition ...
(Date:9/17/2014)... CA / MANILA, PHILIPPINES (PRWEB) September 17, 2014 ... providing Managed Operations and Business Process Outsourcing (BPO) services ... joined the firm as the Senior Vice President – ... U.S.. , Cary Weltken is a 15 year ... a wealth of experience in helping companies, ranging in ...
(Date:9/17/2014)... Freeslate, Inc. , the ... drug development, today announced that Baylor University acquired ... System to both support Baylor research interests and ... high throughput system is expected to significantly accelerate ... optimization for small molecule organic chemistry. , The ...
(Date:9/17/2014)... 17, 2014 Luxury Barber, the purveyor ... their newest addition to the Regenepure family: The Regenepure ... with nourishing and beneficial ingredients including biotin, silk proteins, ... with ample moisture, while also encouraging volume and shine. ... to complement the Regenepure DR doctor recommended ...
Breaking Medicine News(10 mins):Health News:Video Helps Kids and Adults Talk About Concussion Recognition and Treatment 2Health News:ICS Learning Group Wins Gold in the 2014 Brandon Hall Excellence Competition for Best Use of Games and Simulations for Learning 2Health News:MicroSourcing Appoints New Senior Vice President of North America 2Health News:Baylor University Selects Freeslate Reaction Screening System to Support New High Throughput Screening Lab 2Health News:Luxury Barber Adds New Regenepure Biotin Conditioner to Their Selection of Grooming Products 2
... By Steven Reinberg HealthDay Reporter , ... are getting their recommended vaccinations, federal health officials reported ... getting the shots increased 15 percent from 2008 to ... and Prevention. "This is the nation,s report card ...
... A medical researcher at the University of Leicester has made ... Dr Paul Symonds from the Department of Cancer Studies ... particular drug in collaboration with radiotherapy gives significantly better results ... of 1,412 patients from 42 different cancer treatment centres which ...
... HealthDay Reporter , THURSDAY, Aug. 19 (HealthDay News) -- ... increase your risk of dying from a stroke or heart ... for men whose blood pressure was at least 168/100, the ... than non-drinkers if they had downed six drinks on one ...
... 19, 2010The first successful report of using cell-depleted lung as ... embryonic stem cells is presented in a breakthrough article in ... by Mary Ann Liebert, Inc. ( www.liebertpub.com ). The article ... stem cells (ESCs) have the potential to mature into virtually ...
... , THURSDAY, Aug. 19 (HealthDay News) -- The economic downturn ... bank accounts aren,t the only things suffering as unemployment remains ... by Mental Health America and other researchers have found that ... for mental illness, especially such conditions as depression and anxiety. ...
... from an international study she was part of indicates ... cancer survivors are outdated. McNeely, from the Faculty ... surgery are often warned that pressure changes in an ... arm. But the study she did with an Australian ...
Cached Medicine News:Health News:More U.S. Teens Get Recommended Vaccines 2Health News:More U.S. Teens Get Recommended Vaccines 3Health News:Significant advance announced in treatment of cervical cancer 2Health News:Binge Drinking, Hypertension a Deadly Combo 2Health News:Binge Drinking, Hypertension a Deadly Combo 3Health News:Natural lung material is promising scaffold for engineering lung tissue using embryonic stem cells 2Health News:Out of Work May Mean Out of Sorts 2Health News:Out of Work May Mean Out of Sorts 3Health News:Breast cancer survivors don't need to be afraid of air travel: U of A study 2
200 L, Racked, Filtered, Pre-sterilized, 96 tips/rack Recommended for 20, 25, 50, 100 and 200 L pipettes. Can also be used with 300 L pipettes when pipetting 200 L or less....
Inquire...
... Finntip Filters are ideal for ... or for any work where ... are designed for pipetting DNA/RNA ... and other. For applications requiring ...
Inquire...
Medicine Products: